Valuation: Celltrion, Inc.

Capitalization 42,756B 28.92B 24.68B 22.64B 21.41B 39.51B 2,712B 40.38B 266B 105B 1,299B 108B 106B 4,610B P/E ratio 2026 *
33.8x
P/E ratio 2027 * 28.1x
Enterprise value 44.19B 29.89M 25.5M 23.39M 22.13M 40.83M 2.8B 41.74M 275M 108M 1.34B 112M 110M 4.76B EV / Sales 2026 *
8.39x
EV / Sales 2027 * 7.07x
Free-Float
70.87%
Yield 2026 *
0.37%
Yield 2027 * 0.37%
1 day+0.49%
1 week+0.99%
Current month+3.45%
1 month+0.99%
3 months-1.92%
6 months+14.41%
Current year+12.71%
1 week 201,000
Extreme 201000
209,000
1 month 189,300
Extreme 189300
211,000
Current year 187,700
Extreme 187700
251,000
1 year 144,615.38
Extreme 144615.3846
251,000
3 years 119,963.37
Extreme 119963.37
251,000
5 years 119,963.37
Extreme 119963.37
259,410.96
10 years 65,004.08
Extreme 65004.0844
341,497.26
Manager TitleAgeSince
Chief Executive Officer 65 19/03/2015
Chief Executive Officer 42 25/03/2021
President 50 12/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 60 31/03/2005
Director/Board Member 66 -
Change 5d. change 1-year change 3-years change Capi.($)
+0.49%+0.99%+34.62%+32.44% 28.78B
-0.55%-4.80%-7.47%-11.49% 45.74B
+0.03%-2.35%+23.59%+20.88% 34.63B
-4.97%-7.24%+283.88%+482.54% 31.32B
-0.27%-1.62%+22.00%-13.40% 29.49B
-3.85%-4.41% - - 14.85B
-1.25%-1.94%+80.13%+169.01% 14.7B
-9.69%-9.79%+26.93%+2.45% 14.34B
+3.13%-1.74%+3,764.63%+4,023.61% 14.04B
+0.07%-2.59%+157.77%+102.63% 12.35B
Average -1.69%-3.56%+487.34%+534.30% 24.03B
Weighted average by Cap. -1.43%-3.40%+298.99%+337.80%

Financials

2026 *2027 *
Net sales 5,268B 3.56B 3.04B 2.79B 2.64B 4.87B 334B 4.98B 32.75B 12.9B 160B 13.37B 13.09B 568B 6,077B 4.11B 3.51B 3.22B 3.04B 5.62B 386B 5.74B 37.78B 14.88B 185B 15.42B 15.1B 655B
Net income 1,365B 923M 788M 723M 683M 1.26B 86.58B 1.29B 8.48B 3.34B 41.47B 3.46B 3.39B 147B 1,648B 1.11B 951M 873M 825M 1.52B 105B 1.56B 10.25B 4.04B 50.09B 4.18B 4.1B 178B
Net Debt 1,431B 968M 826M 757M 716M 1.32B 90.77B 1.35B 8.9B 3.5B 43.48B 3.63B 3.56B 154B 226B 153M 131M 120M 113M 209M 14.37B 214M 1.41B 555M 6.88B 575M 563M 24.42B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
22/04/26 204,000.00 +0.49% 325,046
21/04/26 203,000.00 -1.22% 446,662
20/04/26 205,500.00 -0.96% 275,719
17/04/26 207,500.00 -0.72% 268,148
16/04/26 209,000.00 +3.47% 561,740
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
204,000.00KRW
Average target price
259,500.00KRW
Spread / Average Target
+27.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock